Cargando…

Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells

We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Revilla, Giovanna, Ruiz-Auladell, Lara, Vallverdú, Núria Fucui, Santamaría, Paula, Moral, Antonio, Pérez, José Ignacio, Li, Changda, Fuste, Victoria, Lerma, Enrique, Corcoy, Rosa, Pitoia, Fabián, Escolà-Gil, Joan Carles, Mato, Eugènia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342163/
https://www.ncbi.nlm.nih.gov/pubmed/37446330
http://dx.doi.org/10.3390/ijms241311153
_version_ 1785072436933296128
author Revilla, Giovanna
Ruiz-Auladell, Lara
Vallverdú, Núria Fucui
Santamaría, Paula
Moral, Antonio
Pérez, José Ignacio
Li, Changda
Fuste, Victoria
Lerma, Enrique
Corcoy, Rosa
Pitoia, Fabián
Escolà-Gil, Joan Carles
Mato, Eugènia
author_facet Revilla, Giovanna
Ruiz-Auladell, Lara
Vallverdú, Núria Fucui
Santamaría, Paula
Moral, Antonio
Pérez, José Ignacio
Li, Changda
Fuste, Victoria
Lerma, Enrique
Corcoy, Rosa
Pitoia, Fabián
Escolà-Gil, Joan Carles
Mato, Eugènia
author_sort Revilla, Giovanna
collection PubMed
description We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) expression has been previously described, it is unknown whether LDL can potentiate the adverse effects of PTC through it. We aimed to investigate whether the presence of LDL might accelerate the oncogenic processes through MAPK pathway in presence or absence of BRAF V600E in two thyroid cell lines: TPC1 and BCPAP (wild-type and BRAF V600E, respectively). LDLR, PI3K-AKT and RAS/RAF/MAPK (MEK)/ERK were analyzed via Western blot; cell proliferation was measured via MTT assay, cell migration was studied through wound-healing assay and LDL uptake was analyzed by fluorometric and confocal analysis. TPC1 demonstrated a time-specific downregulation of the LDLR, while BCPAP resulted in a receptor deregulation after LDL exposition. LDL uptake was increased in BCPAP over-time, as well as cell proliferation (20% higher) in comparison to TPC1. Both cell lines differed in migration pattern with a wound closure of 83.5 ± 9.7% after LDL coculture in TPC1, while a loss in the adhesion capacity was detected in BCPAP. The siRNA knockdown of LDLR in LDL-treated BCPAP cells resulted in a p-ERK expression downregulation and cell proliferation modulation, demonstrating a link between LDLR and MAPK pathway. The modulation of BRAF-V600E using vemurafenib-impaired LDLR expression decreased cellular proliferation. Our results suggest that LDLR regulation is cell line-specific, regulating the RAS/RAF/MAPK (MEK)/ERK pathway in the LDL-signaling cascade and where BRAF V600E can play a critical role. In conclusion, targeting LDLR and this downstream signaling cascade, could be a new therapeutic strategy for PTC with more aggressive behavior, especially in those harboring BRAF V600E.
format Online
Article
Text
id pubmed-10342163
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103421632023-07-14 Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells Revilla, Giovanna Ruiz-Auladell, Lara Vallverdú, Núria Fucui Santamaría, Paula Moral, Antonio Pérez, José Ignacio Li, Changda Fuste, Victoria Lerma, Enrique Corcoy, Rosa Pitoia, Fabián Escolà-Gil, Joan Carles Mato, Eugènia Int J Mol Sci Article We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) expression has been previously described, it is unknown whether LDL can potentiate the adverse effects of PTC through it. We aimed to investigate whether the presence of LDL might accelerate the oncogenic processes through MAPK pathway in presence or absence of BRAF V600E in two thyroid cell lines: TPC1 and BCPAP (wild-type and BRAF V600E, respectively). LDLR, PI3K-AKT and RAS/RAF/MAPK (MEK)/ERK were analyzed via Western blot; cell proliferation was measured via MTT assay, cell migration was studied through wound-healing assay and LDL uptake was analyzed by fluorometric and confocal analysis. TPC1 demonstrated a time-specific downregulation of the LDLR, while BCPAP resulted in a receptor deregulation after LDL exposition. LDL uptake was increased in BCPAP over-time, as well as cell proliferation (20% higher) in comparison to TPC1. Both cell lines differed in migration pattern with a wound closure of 83.5 ± 9.7% after LDL coculture in TPC1, while a loss in the adhesion capacity was detected in BCPAP. The siRNA knockdown of LDLR in LDL-treated BCPAP cells resulted in a p-ERK expression downregulation and cell proliferation modulation, demonstrating a link between LDLR and MAPK pathway. The modulation of BRAF-V600E using vemurafenib-impaired LDLR expression decreased cellular proliferation. Our results suggest that LDLR regulation is cell line-specific, regulating the RAS/RAF/MAPK (MEK)/ERK pathway in the LDL-signaling cascade and where BRAF V600E can play a critical role. In conclusion, targeting LDLR and this downstream signaling cascade, could be a new therapeutic strategy for PTC with more aggressive behavior, especially in those harboring BRAF V600E. MDPI 2023-07-06 /pmc/articles/PMC10342163/ /pubmed/37446330 http://dx.doi.org/10.3390/ijms241311153 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Revilla, Giovanna
Ruiz-Auladell, Lara
Vallverdú, Núria Fucui
Santamaría, Paula
Moral, Antonio
Pérez, José Ignacio
Li, Changda
Fuste, Victoria
Lerma, Enrique
Corcoy, Rosa
Pitoia, Fabián
Escolà-Gil, Joan Carles
Mato, Eugènia
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title_full Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title_fullStr Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title_full_unstemmed Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title_short Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
title_sort low-density lipoprotein receptor is a key driver of aggressiveness in thyroid tumor cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342163/
https://www.ncbi.nlm.nih.gov/pubmed/37446330
http://dx.doi.org/10.3390/ijms241311153
work_keys_str_mv AT revillagiovanna lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT ruizauladelllara lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT vallverdunuriafucui lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT santamariapaula lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT moralantonio lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT perezjoseignacio lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT lichangda lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT fustevictoria lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT lermaenrique lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT corcoyrosa lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT pitoiafabian lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT escolagiljoancarles lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells
AT matoeugenia lowdensitylipoproteinreceptorisakeydriverofaggressivenessinthyroidtumorcells